title: 3,3'-Diindolylmethane Inhibits Flt3L/GM-CSF-induced-bone Marrow-derived CD103(+) Dendritic Cell Differentiation Regulating Phosphorylation of STAT3 and STAT5.
abstract: The intestinal immune system maintains oral tolerance to harmless antigens or nutrients. One mechanism of oral tolerance is mediated by regulatory T cell (Treg)s, of which differentiation is regulated by a subset of dendritic cell (DC)s, primarily CD103(+) DCs. The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, plays an important role in regulating immunity. The intestines are exposed to various AhR ligands, including endogenous metabolites and phytochemicals. It was previously reported that AhR activation induced tolerogenic DCs in mice or in cultures of bone marrow-derived DCs. However, given the variety of tolerogenic DCs, which type of tolerogenic DCs is regulated by AhR remains unknown. In this study, we found that AhR ligand 3,3'-diindolylmethane (DIM) inhibited the development of CD103(+) DCs from mouse bone marrow cells stimulated with Flt3L and GM-CSF. DIM interfered with phosphorylation of STAT3 and STAT5 inhibiting the expression of genes, including Id2, E2-2, IDO-1, and Aldh1a2, which are associated with DC differentiation and functions. Finally, DIM suppressed the ability of CD103(+) DCs to induce Foxp3(+) Tregs.
authors.affiliation: Department of Biology, Changwon National University, Changwon 51140, Korea.
authors.forename: Joo-Hung
authors.initials: JH
authors.lastname: Park
authors.affiliation: Department of Biology, Changwon National University, Changwon 51140, Korea.
authors.forename: Ah-Jeong
authors.initials: AJ
authors.lastname: Choi
authors.affiliation: Department of Biology, Changwon National University, Changwon 51140, Korea.
authors.forename: Soo-Ji
authors.initials: SJ
authors.lastname: Kim
authors.affiliation: Department of Biology, Changwon National University, Changwon 51140, Korea.
authors.forename: So-Yeon
authors.initials: SY
authors.lastname: Jeong
keywords: 3,3'-diindolylmethane; AhR; CD103+ DC; Foxp3+ Tregs; Oral tolerance; STAT5